Bristol-Myers Squibb reports progress from African health programme

20 July 2010 00:00 in Pharmaceutical Company Product News


Bristol-Myers Squibb has highlighted the achievements made in an ongoing scheme to support healthcare initiatives in underprivileged areas in Africa.

Speaking at the XVIII International AIDS Conference in Vienna, the pharmaceutical company reported on the progress of Secure the Future, an anti-HIV and tuberculosis initiative being conducted by its charitable body the Bristol-Myers Squibb Foundation.

The programme is now in its 11th year and is sponsoring a number of community projects across the region, including treatment and screening initiatives and the development of pharmacist-based HIV/AIDS services in southern Africa.

John Damonti, president of Bristol-Myers Squibb Foundation, said that its projects are helping to empower local communities to be able to cope with the impact of the deadly infections.

He added that the programme has now generated "substantial experience in delivering innovative community-based interventions to support the HIV-positive population".

Earlier this month, Bristol-Myers Squibb was granted permission to launch a new paediatric indication of its HIV drug Reyataz in Europe.

Other news stories from 20/07/2010

• Bristol-Myers Squibb reports progress from African health programme
• Athena Medical client Lifeblood honoured with award
• Alliance Healthcare to open Boots pharmacies in Sweden
• Actelion reports growth in second quarter of 2010
• Abbott publishes positive trial data for new HIV regimen
• Orthovita highlights benefits of Cortoss bone material
• Hill-Rom wins award for quality of services
• Philips sees second quarter sales growth
• BD to launch new CD4 testing reagents for HIV treatment
• Thermo Fisher Scientific microtome aids Parkinson's research
• Hospital understaffing 'can cause increased neonatal death risk'

Related news

• Bristol-Myers Squibb to showcase immuno-oncology drugs at ASCO
• Bristol-Myers Squibb and Vertex to study new hepatitis C treatment
• Bristol-Myers Squibb selects Quintiles as lab services provider
• Bristol-Myers Squibb to present hepatitis data at ILC 2013
• Bristol-Myers Squibb appoints new chief scientific officer

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Adfero News Agency

Feedback | News Archive | Browse News | Hotels | Links | Browse Jobs | Legal Notice | Privacy Policy

© Copyright 2013 Zenopa Ltd